Home Sectors Industrials Recent Fundamentals: Impax Laboratories (NASDAQ: IPXL)

Recent Fundamentals: Impax Laboratories (NASDAQ: IPXL)

SHARE

Impax Laboratories is in the sector and is part of the industry.

Previous Intraday Trading Performance:

The IPXL stock showed a previous change of 0.00% with an open at 18.20 and a close of 18.30. It reached an intraday high of 18.95 and a low of 17.40.

PR Newswire:  ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax

Liquidity:

The stock has a market cap of $0 with 0 shares outstanding, of which the float is 0 shares. Trading volume reached 0 shares compared to its average volume of 821,879 shares. Based on the current average volume and close price, the trading liquidity is bad, highly speculative and an investor may want to avoid this stock.

Historical Trading Performance:

Over the last five trading days, Impax Laboratories shares returned -2.66% and in the past 30 trading days it returned -7.11%. Over three months, it changed -8.50%. In one year it has changed 36.06% and within that year its 52-week high was 25.70 and its 52-week low was 13.05. IPXL stock is 40.23% above its 52 Week Low.

Our calculations show a 200 day moving average of 19.16 and a 50 day moving average of 19.60. Currently IPXL stock is trading -4.48% below its 200 day moving average and may be a good opportunity to buy, but should check other indicators to confirm a buy signal.

PR Newswire:  ANI Pharmaceuticals Completes Acquisition of Generic Products and Assets from Amneal/Impax

Earnings:

The last annual fiscal EPS for the company was reported at 0 that ended on 1st of January 1970, which according to the previous close, that is a PE of inf. Based on 5 analyst estimates, the consensus EPS for the next quarter is 0.16. The TTM EPS is 0.63, which comes to a TTM PE of 29.05.

Below was the last reported quarterly diluted earnings per share:

1stQtr of 2019 (Reported on 05/02/2019): 31.32
4thQtr of 2018 (Reported on 02/07/2019): -2.02
3rdQtr of 2018 (Reported on 11/08/2018): 2.80
2ndQtr of 2018 (Reported on 08/06/2018): 2.99
1stQtr of 2018 (Reported on 05/08/2018): 1.83

Indicators to Watch:

Short-interest was 8,917,363, which was inf% of shares outstanding. The short-interest ratio or days-to-cover ratio was 11.87.

The current calculated beta is 1.14.

Fundamental Indicators:

Company Scores:

All scores are out of six:
 3  :Valuation Score
 6  :Past Performance Score
 4  :Financial Strength Score
 0  :Future Growth Score
 0  :Dividend Score
 3  :Overall Score

SHARE
John Jones
Worked for several Wall Street firms: Salomon Smith Barney, UBS, and Charles Schwab. Has developed skills and gained extensive experience over the years that is used today to uncover winning penny stocks.Also was an attorney for small businesses in Scottsdale, Arizona. That experience and understanding of law provides a unique perspective and edge in discovering quality companies in various industries.